Robert Foglesong

Experience

1. Director of Business Development, North America

   Eurofins Selcia

   Jan 2016 — Present

   Selcia is a global contract research provider of 14C radiolabeling services, integrated drug discovery and medicinal chemistry. Established in 2001, Selcia’s two divisions, Selcia Discovery and Selcia Radiolabeling, work in state of the art R+D facilities north east of London (UK). Globally active, Selcia offers a unique range of services to the life sciences community: we have an in-house GLP certified analytical laboratory together with a Good Manufacturing Practice (GMP) certificate for the preparation of 14C labeled APIs operating alongside our integrated drug discovery services. Selcia’s 14C labeling service extends well beyond human health into diverse markets including agrochemicals, animal health, nutrition, cosmetics, flavors and fragrances. Our collaborations and drug discovery ventures span a wide range of organizations, from virtual biotechnology companies to mid-sized pharma and some of the world’s largest pharmaceutical companies. A fully independent organization, we operate with an unusually high degree of freedom allowing us to build innovative and flexible relationships. As the world’s largest independent supplier of custom carbon-14 radiochemicals we have earned a reputation for excellence and success in carrying out the most challenging synthetic projects. For further information or to request a quote please contact me at r••••••••@selcia.com

Education

• Duke University School of Medicine

  Post-Doc

• Massachusetts Institute of Technology

  PhD, Chemistry

  1981 — 1986

• Miami University

  BS, Chemistry

  1977 — 1981